Note: This story was updated Sept. 2, 2025, to clarify the definition of a durable platelet response used in LUNA 3. The U.S. Food and…
News
A woman in Spain delivered a full-term, healthy baby after she was identified early as having congenital thrombotic thrombocytopenic purpura (TTP) and treated successfully…
Daratumumab, an injection therapy approved to treat myeloma, may help to control immune thrombocytopenia (ITP) in individuals whose disease doesn’t respond well to available…
Spark Biomedical has been awarded funding from The Missed Vital Sign, Wellcome Leap’s $50 million program in women’s health, which it will use…
People with immune-mediated thrombotic thrombocytopenic purpura (iTTP) who also have systemic lupus erythematosus (SLE) — have different symptoms and longer periods without disease relapse…
A Phase 3 clinical trial testing ianalumab (VAY736) in combination with Promacta (eltrombopag) in people with primary immune thrombocytopenia (ITP) has met its main…
Increasing the use of Haemate-P to treat von Willebrand disease (VWD) could yield substantial savings for the healthcare system in Spain, a study found.
Platelet transfusions more than double the risk of death among people with thrombotic thrombocytopenic purpura (TTP), according to a review of published studies.
Artificial intelligence (AI) can accurately predict a response to the second-line therapy rituximab in children and adolescents with immune thrombocytopenia (ITP), according to a…
About two-thirds of women with von Willebrand disease (VWD) experience heavy menstrual bleeding, according to a study from Sweden. Data also showed that…
